Today’s Research Reports on Trending Tickers: BioLineRx Ltd. and Opko Health, Inc.
NEW YORK, NY / ACCESSWIRE / November 29, 2017 / U.S. markets closed at record highs Tuesday as the U.S. moved one stepped closer to a tax reform after a recent Senate vote. The Dow Jones Industrial Average spiked 1.09 percent to close at 23,836.71, while the S&P 500 Index jumped 0.98 percent to close at 2,627.04. The Nasdaq Composite Index gained 0.49 percent to close at 6,912.36. The Senate Budget Committee voted 12-11 in favor of advancing the Republicans' tax bill, with Senators Bob Corker and Ron Johnson joining as "yes" votes.
"This is a strong market that continues to grind up, and I expect the market will continue to move higher throughout the end of the year. The market is very comfortable with valuations here, and so long as earnings continue to move up, I don't see that changing," said Wayne Kaufman, chief market analyst at Phoenix Financial Services, according to MarketWatch.
RDI Initiates Coverage on:
BioLineRx Ltd.
https://rdinvesting.com/news/?ticker=BLRX
Opko Health, Inc.
https://rdinvesting.com/news/?ticker=OPK
BioLineRx Ltd.'s stock jumped 7.62% Tuesday, to close the day at $1.13. The stock recorded a trading volume of 2,695,264 shares, which was above its three months average volume of 388,210 shares. In the last year, BioLineRx Ltd.'s shares have traded in a range of 0.80 - 1.38. The share price has gained 41.25% from its 52-week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $1.08 is greater than its 200-day moving average of $1.01. Shares of BioLineRx have gained roughly 5.61 percent in the past month and are up 22.83 percent year-to-date.
Access RDI's BioLineRx Ltd. Research Report at:
https://rdinvesting.com/news/?ticker=BLRX
On Tuesday, shares in Opko Health, Inc. recorded a trading volume of 5,479,647 shares, which was above the three months average volume of 5,043,367 shares. The stock ended the day 1.18% lower at 5.02. The stock is currently trading 58.68% below its 52-week high with a 52-week trading range of 4.50 - 12.15.The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $6.14 is below its 200-day moving average of $6.36. Shares of Opko Health, Inc. have fallen roughly 26.28 percent in the past month and are down 46.02 percent year-to-date.
Access RDI's Opko Health, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=OPK
Our Actionable Research on BioLineRx Ltd. (NASDAQ:BLRX) and Opko Health, Inc. (NASDAQ:OPK) can be downloaded free of charge at Research Driven Investing.
Research Driven Investing
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.
CONTACT
For any questions, inquiries, or comments reach out to us directly at:
Address:
Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011
Email:
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE: RDInvesting.com
